Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Targeting smokers coming and going

This article was originally published in The Tan Sheet

Executive Summary

Reynolds American, the No. 2 U.S. tobacco firm, might enter the smoking-cessation market by acquiring Niconovum, a Swedish firm that manufactures Zonnic nicotine-replacement therapy gum and mouth sprays. Media reported buying Niconovum would align with Reynolds' interest in marketing nicotine products less harmful than cigarettes. The Winston-Salem, N.C.-based company currently is testing dissolvable tobacco tablets in the U.S. after introducing Swedish-style Camel snus earlier this year. Other tobacco firms also likely want to enter the NRT market through acquisitions since Congress instructed FDA to further smoking-cessation efforts in the recently enacted law giving the agency authority over tobacco
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS103537

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel